
Tanie CBD vs dobre CBD – jak nie dać się nabrać 2026
Cheap CBD vs Good CBD 2026: price per mg, COA, isolate masquerading as full spectrum. Up to 70% of labels inaccurate (JAMA, 2017). Check the red flags of marketing.
Hemp oils, gummies, and capsules costing 40 PLN next to products priced at 250 PLN are currently fueling the hottest debate in the Polish CBD market. A staggering 69% of the 84 products tested by the Bonn-Miller, Loflin, and Russo team from Penn State had labels inconsistent with the actual CBD content (CAVITY, 2017). A consumer without knowledge of COA, extraction, and the true price per milligram often ends up buying air.
This guide does not demonize cheap products. Instead, it shows how to distinguish a fair deal from marketing fiction, and why the percentage on the bottle says less than the number of milligrams of CBD per PLN. We cite studies from JAMA, FDA warning letters, FTC decisions, EFSA opinions, UOKiK reports, and GIS recalls, which together create a picture of a market full of cognitive traps.
Dowiesz się, czym różni się izolat udający szerokie spektrum od prawdziwego ekstraktu, kiedy MCT jest nośnikiem, a kiedy zapchajdziurą, oraz jak działa anchoring na cenniku. Pokażemy 11 czerwonych flag, praktyczną tabelę porównawczą i listę kontrolną przed zakupem. Cel: świadomy wybór oparty na danych, nie na bannerze „minus 70% tylko dziś”.
KEY FINDINGS
– Cena za miligram CBD, nie procent na butelce, jest jedyną prawdziwą miarą wartości. Średni koszt 1 mg CBD w produktach z badaniami COA mieści się w przedziale 0,09-0,18 zł (Project CBD, 2023).
– W badaniu JAMA z 2017 roku 69% z 84 testowanych produktów CBD miało etykietę niezgodną z zawartością, a 21% zawierało wykrywalny THC mimo deklaracji „0% THC” (Bonn-Miller i in., JAMA, 2017).
– Brak COA z bieżącej partii to czerwona flaga numer jeden, wskazywana w listach ostrzegawczych FDA od 2015 roku (FDA, 2024).
– Izolat sprzedawany jako full spectrum to częsty scam. Około 30% produktów oznaczonych jako full spectrum w testach okazuje się izolatami (Project CBD, 2023).
– MCT to akceptowalny nośnik, jeśli jego udział i rola są jasno zadeklarowane na etykiecie.
What is the difference between cheap CBD and good CBD?
Cheap CBD and good CBD differ primarily in transparency and the quality of the raw material. In an audit of 84 products from 2017, only 31% had labels consistent with the actual cannabinoid content (CAVITY, 2017). This shows that the promise on the packaging often has little to do with what you are actually buying.
A good product has a clear pedigree. The hemp comes from certified EU farms, extraction is done using supercritical CO2, and each batch has an independent COA available via QR code. The cheaper equivalent often remains silent on key issues: where the raw material comes from, what extraction method is used, and what contaminants may be present.
Price matters, but it is not the only variable. An expensive oil with an impressive label and a celebrity ambassador may have a worse COA than a mid-range product from a Polish manufacturer. What counts is the ratio of milligrams of CBD to PLN, plus real evidence of quality in the form of documents, not advertising slogans.
The three most common differences in practice
Raw material: good CBD comes from industrial hemp (Cannabis sativa L.) grown without pesticides, from organic farming or controlled EU plantations. Cheap CBD often relies on raw materials from less regulated markets, where control over heavy metals and pesticides is weaker. Hemp is a bioaccumulative plant, meaning it absorbs contaminants from the soil (EFSA, 2022).
Extraction: the gold standard is supercritical CO2. It yields a pure extract without solvent residues. Cheaper methods, such as oil maceration or ethanol without thorough evaporation, may leave trace residues. The COA should include a test for residual solvents if a method other than CO2 was used.
Testing: a good manufacturer publishes COA for each batch. Inside, you will find the testing date, batch number, list of cannabinoids (CBD, CBDA, CBG, CBN, THC), terpenes, heavy metals, pesticides, and microorganisms. A cheap manufacturer most often publishes either an old COA for all batches or does not publish one at all.
Price per mg as the only true measure of value
The price per milligram of CBD is the only indicator that allows for fair comparisons of products from different brands. In a review of the Polish market from 2023, the average price of 1 mg of CBD in broad spectrum oils with COA certificates ranged from 0.09 to 0.18 PLN (Project CBD, 2023). A price below 0.05 PLN per mg should raise a red flag.
Counting is simple. Take the price of the bottle, divide it by the total number of milligrams of CBD in the package. A 10 ml bottle containing 10% CBD has 1000 mg of pure cannabinoid. An oil for 99 PLN comes out to 0.099 PLN per mg. An oil for 49 PLN with a declaration of 1000 mg comes out to 0.049 PLN per mg, which is noticeably below market.
A low price per mg does not always mean fraud. Sometimes it is an isolate (cheaper to produce), sometimes a competitive brand reducing margins, and sometimes a batch with an incorrect label. JAMA showed in 2017 that 26% of products contained less CBD than declared, sometimes even 50% less (CAVITY, 2017).
Table: indicative prices per mg on the market 2026
| Concentration | Mg CBD | Market price | Price per 1 mg CBD |
|---|---|---|---|
| 5% | 500 mg / 10 ml | 76-170 PLN | 0.15-0.34 PLN |
| 10% | 1000 mg / 10 ml | 99-250 PLN | 0.10-0.25 PLN |
| 15% | 1500 mg / 10 ml | 180-340 PLN | 0.12-0.23 PLN |
| 20% | 2000 mg / 10 ml | 260-400 PLN | 0.13-0.20 PLN |
Jak widać, cena za 1 mg w stężeniach 5%-20% zbliża się do siebie, gdy mówimy o produktach z badaniami COA. Ofertę 5% za 39 zł reklamującą się jako „organic full spectrum” warto sprawdzić podwójnie. To albo izolat, albo etykieta niezgodna z zawartością.
Percentage trap and what really counts
Sprzedawcy wykorzystują, że klient porównuje procenty zamiast miligramów. Olej „20% w butelce 5 ml” ma 1000 mg CBD, czyli tyle samo co olej „10% w butelce 10 ml”. Cena pierwszego bywa wyższa, mimo identycznej wartości. Zawsze sprawdzaj objętość butelki obok stężenia.
The situation complicates with volumes of 30 ml, 50 ml, and 100 ml. Hemp shots, balms, and hemp cosmetics often have low percentages of CBD with large volumes. An oil with 0.5% in 100 ml contains 500 mg of CBD, which at a price of 90 PLN gives 0.18 PLN per mg. Here, the form of use already affects the real value.
JAMA 2017: why are 70% of labels inaccurate?
A study by Marcel Bonn-Miller's team from Penn State and ICCI published in JAMA in November 2017 examined 84 CBD products purchased online from 31 companies. A staggering 69% had labels inconsistent with the actual CBD content, 26% had less CBD than declared, and 43% had more, which is not a good result (CAVITY, 2017).
Why does this happen? Manufacturers often use cheap raw materials with unstable cannabinoid content, do not standardize final formulations, or deliberately inflate declarations to compete on the shelf. The lack of rigorous regulatory oversight in the supplement segment further facilitates such practices.
Co gorsza, JAMA odnotowała wykrywalny THC w 21% produktów, mimo deklaracji „wolne od THC”. Dla osób testowanych na narkotyki w pracy (kierowcy zawodowi, sportowcy, służby mundurowe) to bardzo poważny problem. Zaufanie do etykiety bez COA jest po prostu naiwne.
In the 2017 JAMA study, 69% of the 84 tested CBD products had labels inconsistent with cannabinoid content, and 21% contained detectable THC despite claims of its absence (Bonn-Miller et al., CAVITY, 2017). This study remains a benchmark for CBD market regulators worldwide.
What has changed since 2017?
The situation has improved, but not dramatically. Later studies, including Gurley's work from the University of Mississippi in 2020, showed about 40-50% of products with incorrect labels, which is still worryingly high. The FDA sent over 200 warning letters to companies selling CBD with false health claims and inconsistent content from 2015 to 2024 (FDA, 2024).
In Poland, GIS recalled 14 CBD products from the market in 2024 for inconsistencies between declarations and actual THC or CBD content (GIS, 2024). This shows that the problem still exists, although oversight is tightening. UOKiK is simultaneously pursuing deceptive pricing practices based on the Omnibus directive.
Lack of COA: why is lack of transparency a red flag?
COA (Certificate of Analysis) is an analytical document from an independent, accredited laboratory that confirms the composition of a given batch of the product. The FDA in warning letters from 2015-2024 cites lack of COA as one of the most common grounds for legal action against CBD sellers (FDA, 2024). Without COA, you are buying by smell, literally.
A good COA contains nine key elements. Batch number and production date. Name of the laboratory and its accreditation (most often ISO 17025). List of cannabinoids with exact amounts in mg/g or percentages. Terpene profile. Heavy metal test (lead, cadmium, arsenic, mercury). Pesticide test. Microorganism test (E. coli, salmonella, yeast, mold). Residual solvent test. Date of testing.
Czerwona flaga: producent pokazuje „certyfikat” bez wyników liczbowych, tylko z logo laboratorium i napisem „OK”. To nic nie znaczy. Pełnowartościowy COA ma wykres HPLC lub GC-MS, tabele z wartościami i często protokół wewnętrzny laboratorium. Skanowalny kod QR na opakowaniu prowadzący do COA dla danej partii to standard branżowy.
How to read a COA step by step
Start with the batch number and date. The number should match the one on the packaging. The testing date should not be older than 6-12 months. Then check the cannabinoid section. Look for CBD, CBDA, CBG, CBN, THC. The sum of cannabinoids in a broad spectrum product should match the declared mg on the bottle, with a deviation of no more than 10-15%.
The contaminants section is equally important. Lead, cadmium, mercury, arsenic should be below the limit of detection or within EU norms for supplements. Pesticides: the most commonly tested are on the EPA list with 70 substances. Microorganisms: E. coli, salmonella, mold, yeast should be absent or below threshold.
Profil terpenowy jest opcjonalny, ale w produktach broad i full spectrum powinien być publikowany. Brak terpenów w COA przy hasłach „pełen aromat konopi” sugeruje, że to jednak izolat z dodanym aromatem.
Isolate masquerading as full spectrum: how to recognize a scam?
An isolate sold as full spectrum is a classic marketing ploy. Project CBD in its 2023 analysis showed that about 30% of products labeled as full spectrum in independent tests turn out to be isolates with added cannabis flavor (Project CBD, 2023). The difference in production cost is 50-70% in favor of the isolate.
Izolat to czyste CBD (>99%) bez pozostałych kannabinoidów i terpenów. Powstaje przez chromatograficzną separację z surowca. Surowiec do izolatu jest tańszy, bo nie wymaga zachowania profilu fitochemicznego. Producent ma izolat za 30-40% kosztu pełnego ekstraktu, ale sprzedaje go z marżą full spectrum.
Without COA, you won't notice this difference. Flavor and aroma can be faked with flavoring, the color of the oil depends on the carrier and extraction. Only a laboratory result gives certainty, where next to CBD you see CBDA, CBG, CBN, CBC, terpenes. In an isolate, these fields are absent or at the level of detection noise.
Why does full spectrum cost more?
Full spectrum requires gentler extraction to preserve the entire cannabinoid and terpene matrix. The raw material must be of higher quality, as it inherits its full phytochemical profile. CO2 extraction with precise temperature and pressure control costs 2-3 times more than simple ethanol extraction or oil maceration.
The entourage effect, described by Russo and Mechoulam in 2011, means that a full profile of cannabinoids provides stronger effects per milligram of CBD than an isolate. This is real value for the user, but requires proof in the form of COA. Without it, you are paying for a slogan, not for a substance.
Project CBD in 2023 estimated that about 30% of products labeled as full spectrum in independent laboratory tests turn out to be isolates with added cannabis flavor, due to even a 70% reduction in production costs compared to true extract (Project CBD, 2023). This is why COA for each batch is the only verification tool.
MCT as a carrier or a scam?
MCT oil (medium-chain triglycerides) is an acceptable and often even desired carrier for CBD. MCT fats increase the oral bioavailability of cannabinoids by 3-5 times compared to other oils (Frontiers in Pharmacology, 2020). The problem only arises when its share in the product is hidden.
Standardowy olej CBD 10% to 1 g ekstraktu plus 9 g oleju nośnikowego (najczęściej MCT, czasem oleju z nasion konopi). To matematyka. 90% formulacji to nośnik, który ma fizjologiczną rolę w transporcie kannabinoidów do krwiobiegu. Sam fakt, że produkt jest „głównie MCT”, nie czyni go oszustwem.
Oszustwo zaczyna się, gdy producent ukrywa skład, używa wieloznacznych haseł typu „olej konopny” (czy to ekstrakt, czy olej z nasion?), lub sprzedaje produkt 95% MCT plus 5% ekstraktu z deklaracją 1500 mg CBD przy realnej zawartości 200 mg. Etykieta INCI powinna jasno wskazywać oba składniki.
Hemp seed oil vs MCT oil vs CBD extract
Olej z nasion konopi (Cannabis Sativa Seed Oil) to wytłoczony z nasion produkt spożywczy. Zawiera kwasy omega-3, omega-6 i witaminę E, ale praktycznie nie zawiera CBD. Sprzedawany jako „olej konopny CBD” jest pomyłką semantyczną lub świadomym wprowadzeniem w błąd.
MCT oil is a refined fat from coconut or palm oil, consisting mainly of caprylic and capric acid. It is flavor-neutral, chemically stable, and promotes the absorption of lipophilic substances like CBD. This is why it dominates as a carrier in cannabinoid products.
Ekstrakt CBD to wynik ekstrakcji z konopi, zawierający rzeczywiste kannabinoidy. Powinien być wymieniony osobno na liście składników, najczęściej jako „Cannabidiol” lub „Cannabis Sativa Flower/Leaf Extract”. Jego brak na etykiecie obok hasła „olej CBD” to czerwona flaga.
Anchoring and fake promotions: how does price psychology work?
Anchoring (efekt zakotwiczenia), opisany przez Kahnemana i Tversky’ego w 1974 roku, to technika manipulacji wykorzystująca pierwszą podaną liczbę jako punkt odniesienia. UOKiK od 2023 roku egzekwuje dyrektywę Omnibus, która wymaga podania najniższej ceny z 30 dni przed promocją (Office of Competition and Consumer Protection, 2024). Nevertheless, many CBD sellers still inflate the base price.
Mechanizm jest banalny. Sprzedawca ustawia „cenę regularną” 299 zł i niemal na stałe wyświetla ją jako przekreśloną. Aktualna „promocyjna” cena 89 zł wygląda przy tym jak okazja stulecia. Tymczasem cena 299 zł nie była realnie pobierana nigdy lub przez bardzo krótki okres.
Banner „minus 70% tylko dziś” wiszący tygodniami to fikcja marketingowa. Dyrektywa Omnibus wymaga podania najniższej ceny z 30 dni przed obniżką, więc rabat liczony jest od tej najniższej ceny, a nie od fikcyjnej „regularnej”. UOKiK nakłada kary do 10% rocznych obrotów za naruszenia.
Other pricing tricks used in CBD
Scarcity (sztuczny niedobór): „tylko 3 sztuki w magazynie”, „kończy się za 2 godziny”. To psychologiczny przycisk pilności, który skraca czas refleksji. Realny stan magazynowy najczęściej jest większy. UOKiK ściga praktyki podawania nieprawdziwych informacji o dostępności.
Bundle pricing (sztuczne pakiety): „kup 2 olejki, trzeci za grosz”. Producent zawyża cenę pojedynczego produktu, żeby pakiet wyglądał jak okazja. W przeliczeniu na 1 mg CBD pakiet często nie jest tańszy od konkurencji w wersji single.
Decoy pricing (wabik): trzy warianty cenowe, gdzie środkowy jest „nielogicznie” droższy od najtańszego, a lekko tańszy od najdroższego. Klient wybiera najdroższy, bo wygląda jak najlepsza wartość. Olejek 5%-10%-20% z cenami 79-179-219 zł to typowy przykład.
Fake reviews: how to recognize fakes?
FTC (Federal Trade Commission) in 2023 introduced a ban on publishing fake reviews online, with a penalty of up to 50,000 USD for a single case (FTC, 2023). Nevertheless, the CBD market is full of review factories, especially on Amazon and smaller marketplaces. Polish stores are also not free from this practice.
Sygnały podróbki są spójne. Skrajnie ogólne pochwały bez szczegółów dawkowania („super produkt!”, „polecam każdemu!”). Identyczne sformułowania w wielu opiniach na różnych platformach. Brak wzmianki o reakcjach niepożądanych, mimo że JAMA w 2017 roku odnotowała senność u 12% użytkowników CBD.
Concentration of reviews in a short time is another red flag. If a store receives 50 five-star reviews in one day after months of silence, it is most often the purchase of a review package from a broker. Real reviews come in gradually and have varied lengths, styles, and structures.
Characteristics of an authentic CBD review
Autentyczne opinie wskazują konkretną dawkę („zaczynałam od 10 mg, dziś biorę 25 mg wieczorem”), czas używania („po 3 tygodniach zauważyłam”), porównanie do innych produktów („wcześniej miałam olejek X marki Y”) oraz mieszane oceny („zasypianie się poprawiło, ale ranny refluks pozostał”).
Pay attention to 3- and 4-star reviews. They are often more valuable than enthusiastic fives. They show real limitations of the product, suggest who it may not suit, and are less prone to being faked. Manufacturers do not buy packages of average reviews because they do not raise the average rating.
Check the reviewer's profile. Do they have other reviews? Are they from different categories? A reviewer who wrote 50 fives for different CBD stores in one week is most likely a bot farm.
Red flags when buying CBD: full list
The Polish Chief Sanitary Inspectorate recalled 14 CBD products from the market in 2024 for inconsistencies with the declared cannabinoid content or exceeding the THC limit (GIS, 2024). GIS data, FDA warning letters, and UOKiK decisions allow us to build a list of the 11 most common red flags when purchasing CBD.
Each of the following features does not necessarily indicate fraud on its own. But when several are combined, the likelihood that you are dealing with a low-quality product or even a scam increases sharply. Treat the list as a scoring system: 3+ flags = withdraw from the transaction.
List of 11 red flags
- No COA for the current batch. The manufacturer shows an old certificate for all batches or none at all.
- Promises of curing diseases. „Wyleczy raka”, „zastąpi leki przeciwdepresyjne”, „leczy padaczkę” – to nielegalne oświadczenia zdrowotne.
- Eternal promotion of 70% off. A banner with a discount hangs for weeks, the base price is fictitious.
- No type of extract on the label. It is unclear whether it is an isolate, broad spectrum, or full spectrum.
- No data on the origin of the hemp. Kraj uprawy, certyfikat ekologiczny, odmiana – cisza.
- No extraction method. CO2, ethanol, oil maceration? The manufacturer does not inform.
- No mg of CBD on the label. Only percentage, no conversion to milligrams.
- Price per 1 mg below 0.05 PLN. Market anomaly, signal of an isolate or incorrect label.
- Reviews concentrated in time. 50 fives in one day after months of silence.
- Packaging pretending to be medicine. White-blue box with organ icons, slogans like drug leaflets.
- No company data. No NIP, registered address, contact phone, return policy.
Always check points 1-7. Treat points 8-11 as additional signals. If you find 3 or more flags in one product, choose a competitor. The Polish CBD market is now developed enough that transparent brands are easily available.
What is worth paying more for in a CBD product?
EFSA in its scientific opinion from 2022 confirmed that the quality of the oil matrix and the purity of the raw material determine the safety profile of cannabinoids (EFSA, 2022). This is why an additional 30-50% for a truly quality product is a rational investment in safety, not a marketing whim.
The first element is CO2 extraction instead of ethanol. It yields a cleaner extract without the risk of solvent residues. The second issue is broad or full spectrum instead of isolate, meaning the entourage effect and a full terpene profile. The third thing is COA for each batch, not once a year.
The fourth factor is origin from certified EU farms. Poland, the Czech Republic, Lithuania, Estonia, and Germany have strict standards for pesticides and heavy metals. Raw materials from less regulated markets may be cheaper, but the risk of contamination is higher. Hemp is a bioaccumulative plant.
Table: cheap CBD vs good CBD
| Characteristic | Cheap CBD | Good CBD |
|---|---|---|
| Price per 1 mg CBD | below 0.05 PLN | 0.09-0.18 PLN |
| COA | none or old | current for each batch |
| Extract type | most often isolate | broad or full spectrum |
| Extraction | ethanol, maceration | supercritical CO2 |
| Origin of hemp | unknown | EU, certified crops |
| Terpene profile | none or added flavor | natural, in COA |
| Mg CBD on the label | only percentage | percentage + milligrams + drops |
| Marketing | miracle promises, 70% off | education, facts, COA |
| Reviews | massive, general, concentrated | gradual, detailed, mixed |
What is not worth the extra payment
Drogie marketingowo opakowania, ekskluzywne pudełka z aluminium i celebryckie kampanie potrafią dodać 30-50% do ceny bez realnej wartości produktowej. Limitowane edycje „premium” często mają identyczny COA jak standardowa linia. Płacisz za branding, nie za substancję.
Modne dodatki w olejku CBD typu „z melatoniną”, „z ashwagandhą”, „z magnezem” zwykle zawierają śladowe dawki tych substancji. Dla efektu klinicznego potrzeba 100-300 mg ashwagandhy, 200-400 mg magnezu, 0,5-3 mg melatoniny. W olejku 10 ml zwykle jest 1/10 tej dawki, więc to bardziej hasło niż realny składnik.
Marketingowe hasła „ultra mocne”, „x3 wchłanianie”, „turbo formuła” nie są poparte dowodami. Bez COA i danych o nanoemulsji lub liposomalnej formulacji, „turbo” znaczy nic. Zwykła ekstrakcja CO2 w MCT daje 13-19% biodostępności, niezależnie od tego, jak producent nazywa swój produkt.
Practical quality checklist before purchase
Przed dodaniem produktu CBD do koszyka przejdź przez listę 12 pytań. Każde „tak” zwiększa prawdopodobieństwo, że kupujesz dobry produkt. Każde „nie wiem” lub „nie” obniża to prawdopodobieństwo. Próg akceptacji: minimum 9 z 12 odpowiedzi pozytywnych.
12 questions before purchase
- Do I see the batch number on the packaging and COA for this specific batch?
- Is the COA from an independent, accredited laboratory (ISO 17025)?
- Does the COA list cannabinoids, terpenes, heavy metals, pesticides, and microorganisms?
- Does the label provide milligrams of CBD in the package, not just the percentage?
- Can I calculate the price per 1 mg of CBD, and does it fall within the range of 0.09-0.30 PLN?
- Does the manufacturer specify the type of extract (isolate, broad spectrum, full spectrum)?
- Is the extraction method known (preferably CO2)?
- Is the country of origin of the hemp specified (preferably EU)?
- Does the label contain the carrier oil (MCT or hemp seed oil) and CBD extract separately?
- Does the product marketing avoid promises of curing diseases?
- Are the product reviews varied, specific, and spread over time?
- Does the store have clear company data: NIP, address, phone, return policy?
Lista może wydawać się surowa, ale dobre marki spełniają wszystkie 12 punktów bez problemu. Trzy lub więcej „nie” to znak, że warto poszukać alternatywy. W Polsce 2026 roku nie musisz iść na kompromis: transparentne sklepy z certyfikatami COA są łatwo dostępne online i stacjonarnie.
How to safely test a new CBD product?
Even a quality product should be introduced gradually. WHO in a review from 2018 assessed CBD as well-tolerated up to a dose of 1500 mg daily in adults, but noted individual differences in sensitivity (WHO, 2018). Protokół „start low, go slow” jest standardem dla suplementów kannabinoidowych.
The principle is simple. Start with 5-10 mg of CBD daily for the first 3-7 days. Observe the reaction: sleep quality, stress level, any side effects (drowsiness, dry mouth, headaches, stomach issues). If everything is stable, increase to 15-20 mg.
After 2 weeks, assess the overall effect. CBD does not work like a tranquilizer with an immediate effect, but as a modulator of the endocannabinoid system, which reaches full activity after 2-4 weeks of regular use. Patience pays off.
When to consult a doctor?
CBD and CBG inhibit cytochrome P450 enzymes, mainly CYP3A4 and CYP2C9. This can affect the metabolism of many medications, including warfarin, statins, antiepileptics, and some antidepressants (PMC, 2019). Before combining CBD with medications, consult a doctor or pharmacist.
Consultation is especially important for individuals taking antiepileptics, anticoagulants, heart medications, medications for autoimmune diseases, antidepressants, and anxiolytics. During pregnancy, breastfeeding, and in children, CBD is not recommended without a doctor's indication due to the lack of long-term safety studies.
How to calculate dosing from milligrams to drops?
Project CBD in its 2023 dosing guide recommends a typical starting dose of 10-20 mg of CBD daily for an adult (Project CBD, 2023). Most oils have a dropper calibrated for drops, so you need to convert milligrams to the number of drops.
Standard conversion: 1 drop of 5% oil is about 2.5 mg of CBD, 10% oil is about 5 mg of CBD, 15% oil is about 7.5 mg of CBD, 20% oil is about 10 mg of CBD. A dose of 20 mg daily with 10% oil is 4 drops. Most 10 ml bottles contain 200 drops, which is enough for 50 days at a dose of 4 drops daily.
Sublingual dosing: hold drops under the tongue for 60-90 seconds before swallowing. This allows cannabinoids to be absorbed through the mucous membrane directly into the bloodstream, bypassing the first-pass effect through the liver. The bioavailability of this form reaches the upper limit of the range of 13-19%.
Legal and regulatory aspects 2026
The Polish CBD market operates at the intersection of several legal regimes. EFSA has been conducting a Novel Food procedure for CBD since 2019, which we expect to conclude in 2026-2027 (EFSA, 2022). Meanwhile, products are sold as cosmetics, dietary supplements in a gray regulatory area, and collectibles.
The THC limit in products from industrial hemp in Poland is 0.3% (Journal of Laws 2005 No. 179 item 1485). Imported products must meet the Polish limit, regardless of origin. GIS regularly monitors the market and recalls non-compliant batches. UOKiK pursues unfair pricing and marketing practices.
Advertising CBD is subject to restrictions. Unauthorized health claims by EFSA cannot be used. The product cannot be presented as a medicine. It cannot be suggested that the supplement replaces pharmacological therapy. Violating these rules risks administrative penalties and product recall decisions.
A verified CBD store: what to pay attention to?
Choosing a seller is as important as choosing a product. A good store publishes COA for each batch, has clear company data with NIP and address, follows consumer law return policies, and offers substantive support. More about this, how to find a good CBD store, can be found in a separate guide.
Contact is an important test. Call or write a question about COA, raw material origin, extraction method. A store that responds specifically and within 24 hours is of a different quality than one that ignores messages or refers to a generic FAQ page. Substantive support is also a test of the team's knowledge.
An educational blog with sources and links to studies signals that the brand treats the customer as a partner in health decisions, not just as a consumer. Superficial marketing content or copied from competitors is a sign that priorities lie in sales, not education.
Alternative hemp forms
CBD oil is the standard, but not the only form. For those preferring tasty forms, alternatives are hemp jellies, capsules for convenient dosing, or dried hemp for those using vaporization. Regardless of the form, the quality criteria remain the same: COA, origin, extract, transparency.
Hemp shots and topicals (ointments, balms) work locally or are specially formulated. When choosing a CBD ointment for joint pain or flavored hemp shots, check the same parameters: type of extract, mg of CBD, COA, origin. The form differs, but the evaluation criteria remain constant.
If you are considering CBD in the context of chronic pain or a specific health issue, check out the separate material CBD and chronic pain: what science says and what marketing claims. There we discuss detailed dosing protocols and the limitations of current clinical research.
Frequently asked questions
Why is cheap CBD so suspicious in quality?
In the 2017 JAMA study conducted by Bonn-Miller, Loflin, and Russo from Penn State and ICCI, 69% of the 84 tested CBD products had labels inconsistent with the actual cannabinoid content (CAVITY, 2017). Extremely low prices usually indicate savings on raw materials, CO2 extraction, and independent laboratory testing. Lack of COA for a given batch is the number one red flag.
How to calculate the true price per milligram of CBD?
Divide the price of the bottle by the number of milligrams of CBD in the package, not by percentages. A 10% oil in a 10 ml bottle contains about 1000 mg of CBD. The average cost of 1 mg in broad spectrum products with laboratory testing falls within the range of 0.09-0.18 PLN according to a review of the Polish market (Project CBD, 2023). Prices below 0.05 PLN per mg signal either an isolate or a label inconsistent with the content.
What is COA and what should it contain?
COA (Certificate of Analysis) is a report from an independent laboratory for a specific batch of the product. It should list: cannabinoid content (CBD, CBDA, CBG, THC), pesticide residues, heavy metals, mycotoxins, microorganisms, and solvents. The FDA in warning letters from 2015-2024 has indicated lack of COA as a frequent ground for legal action against CBD sellers (FDA, 2024).
What does an isolate masquerading as full spectrum mean?
It is a CBD isolate (purity over 99%) sold under the full spectrum label, even though it contains no additional cannabinoids or terpenes. Project CBD in its 2023 analysis indicated that about 30% of products labeled full spectrum in laboratory tests turned out to be isolates with added cannabis flavor (Project CBD, 2023). Without a cannabinoid list on the COA, one cannot distinguish between the two.
Is MCT as a carrier a scam?
No, if it is clearly declared on the label. MCT oil from coconut is a standard carrier for CBD because it improves oral bioavailability by 3-5 times compared to other fats (Frontiers in Pharmacology, 2020). The problem arises when the manufacturer hides the fact that the product is 95% MCT and only 5% extract, while simultaneously suggesting 1500 mg of CBD. This is pure manipulation of consumer expectations.
Why do stores use eternal promotions of 70% off?
To technika anchoringu, opisana przez Tversky’ego i Kahnemana w 1974 roku. UOKiK od 2023 roku egzekwuje dyrektywę Omnibus, która wymaga podania najniższej ceny z 30 dni przed promocją (Office of Competition and Consumer Protection, 2024). Nevertheless, many CBD sellers still inflate the base price. A banner of 70% off hanging for weeks is a sign that the catalog price is a marketing fiction.
How to recognize fake product reviews for CBD?
FTC in 2023 introduced a ban on publishing fake reviews, with a penalty of up to 50,000 USD for a single case (FTC, 2023). Signals of fakes include extremely general praises without dosage details, identical phrases in many reviews, lack of information on adverse reactions, and concentration of reviews in a short time. Authentic reviews indicate a specific dose, duration of use, and comparison to other products.
What are the biggest red flags when buying CBD?
No COA for the current batch, promises of curing specific diseases (cancer, epilepsy, depression), eternal promotions of 70% off, hiding the type of extract, lack of data on the origin of the hemp and extraction method. GIS recalled 14 CBD products from the Polish market in 2024 for inconsistencies with the declared cannabinoid content (GIS, 2024). These are the number one red flags according to Polish sanitary supervision.
What is worth paying more for in a CBD product?
For CO2 extraction instead of ethanol (lower risk of solvent residues), for broad or full spectrum instead of isolate (entourage effect), for COA for each batch, for origin from certified EU crops, and for clear declaration of mg of CBD and mg of other cannabinoids. EFSA in its 2022 opinion confirmed that the quality of the oil matrix and the purity of the raw material determine the safety profile (EFSA, 2022).
Does a high price guarantee high quality?
Not automatically. Expensive marketing packaging, exclusive boxes, and celebrity campaigns can add 30-50% to the price without real product value. What matters is the price-to-mg CBD ratio with confirmed quality. A review of the Polish market in 2024 showed that 5% oils in the range of 76-170 PLN achieve comparable COA results (Hemp Facts, 2024). The most expensive does not always mean the best.
Summary: informed choice over marketing
Spór „tanie CBD czy dobre CBD” rozstrzyga się w trzech liczbach i jednym dokumencie. Liczba jeden to cena za 1 mg CBD, najlepiej w przedziale 0,09-0,18 zł. Liczba dwa to deklarowane miligramy CBD na opakowaniu, nie sam procent. Liczba trzy to limit THC poniżej 0,3%. Dokument to COA dla aktualnej partii.
The rest are consequences. A transparent manufacturer in pricing is also transparent about the origin of the raw material, extraction method, and laboratory results. A manufacturer hiding one element usually hides the others as well. JAMA, FDA, FTC, GIS, and UOKiK have shown that a low price is a weak predictor of quality, and a high price is not a guarantee of it.
If you are starting your journey with cannabinoids, choose a broad spectrum oil of 5% or 10% with a current COA, CO2 extraction, and a clear declaration of milligrams of CBD on the bottle. Start with 10-20 mg daily, observe the reaction for 2-4 weeks, adjust the dose. This is a simple principle that saves money and protects against marketing traps.
This article is for informational and educational purposes and does not constitute medical advice. Before starting to use CBD or other cannabinoids, consult a doctor, especially if you are taking medications, are pregnant, breastfeeding, or have chronic diseases. CBD may interact with medications metabolized by cytochrome P450 enzymes.
Author: Michał Waluk, Editor of the Bucha blog
Publication date: April 26, 2026
Next update: April 26, 2027






